Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Vascular gets clearance for Dura-Guard:

This article was originally published in Clinica

Executive Summary

Bio-Vascular has received US 510(k) clearance to market Dura-Guard, its repair patch for neurosurgery. Surgeons normally use either the patient's own tissue, which requires a second procedure, or tissue-bank material, which carries a risk of infection. The patch, which is made from bovine pericardium will be launched at the Joint International Congress on Minimally Invasive Techniques in Neurosurgery and Otolaryngology in Pittsburgh later this month.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091945

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel